Posts Tagged 'New England Compounding Center lawsuit'

House inches toward oversight of compounding

Congress is wrangling with the issue of where to draw the line between state and federal oversight of large-scale compounding pharmacies in light of a series of infections — including a deadly fungal meningitis outbreak — linked to the facilities. There now appears to be general agreement the FDA needs more clear authority over compounding manufacturers — pharmacies that compound bulk supplies of drugs in advance of a patient prescription.

Read more about the oversight of compounding pharmacies…

States take lead on compounding pharmacies

Several states are taking matters into their own hands to boost oversight of large-scale pharmacies like the one behind the deadly fungal meningitis outbreak last fall as the outlook for congressional action is somewhat murky. So far, 15 states have taken up bills to step up the regulation of facilities like the one linked to the outbreak.

Read more about the compounding pharmacy regulation…

Meningitis outbreak: Bills mount as victims still suffer

Dozens of Tennessee residents continue to experience health problems and mounting expenses from the fungal meningitis outbreak more than six months after it began.  While many have filed lawsuits, most have been put on hold because the supplier of the tainted drugs filed for bankruptcy late last year.

Read more about the compounding pharmacy meningitis outbreak…

Compounding pharmacies linked to deaths over the past decade

A Washington Post investigation has found that shoddy practices and unsanitary conditions at compounding pharmacies like the New England Compounding Center (NECC) have been harming people for the past decade. At least four pharmacies have been linked to 51 deaths and 700 illnesses over the past ten years, including the 45 deaths linked to contaminated steroid injections shipped by the NECC.

Read more about the link between compounding pharmacies and death…

Grand jury sets sights on New England Compounding Center

A federal grand jury in Boston has begun investigating the Framingham compounding pharmacy that made the tainted steroid injections blamed for at least three dozen deaths in seven states, according to several people familiar with the matter, including one who has been called to testify. The development is the latest sign that federal prosecutors are pursuing potential criminal charges against the companies or people deemed responsible for the outbreak.

Read more about the federal grand jury investigation…

Chairman of Senate Health Committee pushes to tighten oversight of drug facilities

The Chairman of the Senate Health Committee has pledged to tighten oversight of drug compounding facilities like the New England Compounding Center (NECC) responsible for the deadly meningitis outbreak. Senator Tom Harkin made the commitment during a Senate hearing in which the Food and Drug Administration (FDA) was questioned on the fungal meningitis outbreak linked to the NECC.

Read more about the regulation of compounding pharmacies…

New England Compounding meningitis suits can proceed

Lawsuits against New England Compounding Pharmacy Inc. over cases of fungal meningitis linked to the company’s injectable steroids can move forward and evidence must be preserved, a federal judge said. The company had asked U.S. District Judge Dennis Saylor in Boston to delay a dozen lawsuits filed in federal court in Massachusetts pending a decision next year by the Judicial Panel on Multidistrict Litigation on which court should hear the hundreds of cases pending nationwide.

Read more about New England Compounding Center lawsuits…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 435 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.